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Recovery of mice  from  primary  infection  with  ectromelia  virus,  a  natural  mouse 
pathogen,  has  been  shown  to  depend  on  cell-mediated  immunity  (CMI) 1 (1-3).  The 
specific effector cells are known to be thymus-derived lymphocytes (T cells)  (2-6).  CMI 
can be measured in two ways. First,  by transferring immune T  cells  into preinfected 
recipients  and  quantitating  virus  clearance  in  vivo (2,  3,  6).  Second,  by  measuring 
cytolysis of virus-infected target cells caused by cytotoxic T cells in vitro (4, 5). These two 
different functions may be mediated by the same T-cell  subset since they both require 
compatibility at the K  or D  region of the H-2  gene complex between T-cell  donors and 
recipients  2 or target cells (7), respectively, and display similar kinetics of effector cell 
production in  the  spleen. 3 The  primary response,  as  measured  by the  generation  of 
cytotoxic T cells in the spleen, is detectable 2 days after infection, reaches a peak on days 
5-6, and then declines to low levels by day 10 (4). 
Furthermore,  when immune spleen cells taken from mice infected 12 or more days 
previously are  cultured  with  virus-infected  spleen  cells  in  vitro,  a  strong secondary 
response  is  elicited  as  indicated  by the  generation  of potent  cytotoxic T  cells. 3 This 
response, however, is not observed with 8 or 10-day immune cells. 3 This suggests that the 
mechanisms responsible for the decline of the primary response (after day 6) and for the 
period where the cells are 'refractory' to secondary stimulation (days 8-10 postimmuniza- 
tion) are no longer exerting their effects after day 12 when a strong secondary response 
can be  produced in  vitro.  The  importance of a  secondary T-cell response  in  resisting 
reinfection is not known, but it is potentially significant if virus evades neutralization by 
antibody and succeeds in spreading from the portal of entry to crucial target organs such 
as  liver  and  spleen  (1-3).  Furthermore,  little  is  known about  the  regulation  of cell- 
mediated immune responses in general, and it is thus of considerable interest to deter- 
mine  what  factors  may be  involved in  controlling the  primary  and  secondary  CMI 
response to a natural virus infection. 
This report describes the results of investigations of mechanisms involved in 
regulating  the  primary  immune  response  to  ectromelia  virus  infection.  The 
rationale of our approach is as follows: if there are regulatory factor(s) present in 
the  spleen  and/or  serum  of infected  animals,  their  effects  can  be  studied  by 
1Abbreviations  used  in  this  paper:  CMI, cell-mediated immunity;  F-15, Eagle's  minimum 
essential medium with nonessential  amino acids. 
Kees, U., and R. V. Blanden. 1976. A single genetic element in H-2K affects T-cell antiviral 
function in poxvirus infection. J. Exp. Med. In press. 
3 Gardner, I., and R. V. Blanden. Manuscript in preparation. 
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injecting the spleen cells or serum into recipient animals after an immunizing 
dose of infectious virus.  It was found that ectromelia-immune  spleen cells and 
serum when injected into preinfected mice suppressed the primary response as 
indicated  by  decreased  cytotoxic  cell  activity  in the  spleen.  Further  analysis 
suggested that such a suppressive effect is most probably due to removal of virus 
and infected cells bearing the antigens necessary to induce the response. 
Materials and Methods 
Animals.  Mice of various strains were  obtained from breeding colonies in this laboratory. 
They were used at 7-10 wk of age.  Unless stated otherwise, CBA/H mice were used. 
Virus.  Virulent Moscow strain and attenuated Hampstead Egg strain ectromelia virus were 
used. The method of growing and titrating these strains has been described previously (4). 
Bacteria.  The preparation ofListeria monocytogenes  inocula has been described previously (2). 
Immunization  of Mice.  Mice  were  infected intravenously (i.v.)  with  2  ×  104 PFU  (plaque 
forming units) of Hampstead  Egg strain ectromelia virus (unless otherwise stated) or with 103 
viable Listeria monocytogenes.  Spleens were removed at various times after immunization, and 
groups of three organs were pooled for the preparation of cell suspensions. 
Spleen Cell Suspensions.  Spleens were treated as described previously (4,  8),  and cells were 
finally suspended in Eagle's minimum essential medium with nonessential amino acids (F-15). 
Anti-SSerum.  Anti-8 serum was obtained from AKR/J mice injected intravenously with 2.5 × 
107 thymocytes from C57BL/6 mice. Sera were collected 1 wk later and tested for specificity against 
CBA/H T cells as described previously (8). Immune spleen cells were suspended at 5  x  107 viable 
cells/ml in a  one-tenth dilution of anti-8 serum and incubated at room temperature for 30 rain. 
After  washing  twice,  the  cells  were  resuspended  in  a  one-fourth  dilution  of absorbed  rabbit 
complement  in  F-15  and  again  incubated at  37°C  for 30  rain  (complement was  absorbed with 
outbred and CBA/H mouse spleen cells until all nonspecific activity was removed). After two more 
washes, the cells were resuspended in F-15 and viability determined by trypan blue exclusion. 
Cell Culture.  Continuous  line mouse  fibroblasts (L-929)  and  mastocytoma  cells  (P-815-X2) 
were grown as described previously (4). 
Cytotoxic  Assay.  The  method  used  was  essentially similar to that described previously  (4) 
except that L-929 target cells were labeled with '~lCr, infected with virus, and dispensed while in 
suspension (as for P-815-X2 cells). 
Thymectomy.  Mice were thymectomized at 8 wk of age by the method of Miller (9). 
Results 
Suppressive Activity of Ectromelia-Immune  Spleen Cells and Serum.  Ectro- 
melia-immune spleen cells and serum obtained 7 or 10 days after immunization 
of donors were injected  into recipient  mice  1-2 h  after an immunizing dose of 
virus. Spleen cells of recipients were then assayed 6 days later (the time of the 
peak  of the primary response)  (4)  for cytotoxic  activity  against  virus-infected 
target cells. Ectromelia-immune spleen cells, and to a lesser extent serum, had 
a suppressive effect on the primary response as indicated by decreased cytotoxic 
cell activity in the spleens of recipients (Table I). 7- or 10-day immune cells did 
not seem  to differ  markedly  in  their  ability  to suppress,  but  10-day immune 
serum appeared to be superior to 7-day serum; normal cells and serum had no 
suppressive effect (Table I). 
Suppressive Effects of Immune Cells and Serum Injected at Different Times 
Relative  to  Immunization.  The  suppressive  effect  described  above  was  ob- 
served when the cells or serum were injected 1-2 h after an immunizing dose of 
virus.  When  the  injection  was  delayed  further,  the  suppressive  effect  was 
observed when they were injected 1 day, but not 2 days, after virus (Table II). T°  PANG  AND  R.  V.  BLANDEN  471 
TABLE I 
Suppression of Primary Response by 7- and lO-Day Immune Spleen Cells and Serum 
Serum or cells injected*  Percent specific slCr release 
from infected L-929 cells$  Percent suppression§ 
None  57.8 I[ -  2.2  0 
Normal  serum  54.7  _  1.3  5.4 
Normal  cells  56.6  +_ 1.1  2.1 
Immune  serum (7-day)  52.4  -+ 3.6  9.3 
Immune  cells  (7-day)  5.8  _+ 1.2  90.0 
None  44.0  _+ 2.7  0 
Normal serum  46.7  +- 1.4  0 
Normal cells  50.2  -  4.3  0 
Immune serum (10 day)  23.4  _+ 4.0  46.8 
Immune cells (10 day)  7.8  _+ 1.3  82.3 
* CBA/H mice were injected with 5 × 104 PFU attenuated ectromelia virus; 1-2 h later they were 
injected with normal or immune serum (0.6 ml per mouse i.v.), normal or immune spleen cells 
(1.2 x l0  s cells per mouse i.v.), or received no further treatment.  Spleen cells from pools of three 
mice were then assayed 6 days later for cytetoxic activity as described in the text. Donors of  cells 
and serum examined for suppressive activity were immunized as described in the text. 
Means  _+  SE of the mean in groups of four wells with  spontaneous release  (release in wells 
containing only medium and target cells) subtracted.  Killer to target ratio was 100:1. 
§ Percent specific slCr release from those spleen cells obtained from mice receiving virus only is 
taken as 100% release (or 0% suppression). 
H  Significantly greater release than from uninfected L-929 cells (P < 0.001). 
Ability of Different Immune Spleen Cell Populations to Suppress the Primary 
Response.  The kinetics of the production of cells with suppressive effect were 
investigated.  Ectromelia-immune spleen  cells  were  obtained at various times 
after primary immunization and their suppressive activity assayed. Cells were 
again injected  into recipients  1-2  h  after  virus,  and  cytotoxic activity in  the 
spleen was determined 6 days later.  Suppressive activity was detected with 4- 
day  immune  cells,  reached  a  maximum  with  6-day immune  cells,  and  then 
declined (Fig.  1). 
Specifwity  of Suppressive  Effect.  The  ability  of immune  spleen  cells  and 
serum  to  suppress  appears  to  be  specific;  spleen  cells  and  serum  from  mice 
infected with Listeria monocytogenes,  a  bacterium that induces a  strong T-cell 
response (8),  had little  suppressive  activity (Table III). It was also found that 
allogenic immune spleen cells (from BALB/c mice) did not possess suppressive 
activity  in  CBA/H  recipients,  and  that  F1  hybrid  cells  (CBA/H  ×  BALB/c) 
appeared  to be  less  effective than  parental  cells  (Table  IV).  BALB/c immune 
cells  had  potent  suppressive  activity  when  injected  into  BALB/c (syngeneic) 
recipients, however, and F~ cells once again appeared to be less effective (Table 
IV). Immune spleen cells from A.TL mice (which share/-region genes of the H-2 
gene complex, but not K- or D-region genes with CBA/H) had little suppressive 
activity in CBA/H mice,  but were potent suppressors of the primary response 
when injected into BALB/c mice (which share D-region genes with A.TL) (Table 
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TABLE II 
Suppressive  Effect of lO-Day Immune Cells and Serum Injected at Different  Times 
Relative to Immunization 
Serum or cells injected* 
Time of injection  Percent specific 51Cr 
release from infected L-  Percent suppres- 
after virus  sion§  929 cells$ 
None  --  44.0 Pl ±  2.7  0 
Normal serum  2 h  46.7  ±  1.4  0 
Normal cells  2 h  50.2  ± 4.3  0 
Immune serum  2 h  23.4  ± 4.0  46.8 
Immune cells  2 h  7.8  ±  1.3  82.3 
None  --  31.3 II -+ 3.0  0 
Normal serum  1 day  29.3  ±  1.2  6.4 
Normal cells  1 day  38.5  ±  1.1  0 
Immune serum  1 day  15.4  ± 2.0  50.8 
Immune cells  1 day  20.3  ±  1.3  35.1 
None  --  48.1 [[ _+ 3.7  0 
Normal serum  2 days  50.4  ±  1.6  0 
Normal cells  2 days  54.7  ± 4.0  0 
Immune serum  2 days  60.6  + 3.3  0 
Immune cells  2 clays  54.8  _+  1.9  0 
* Experimental procedure as for Table I except that cells or serum were injected into recipient 
mice at various times (2 h, 1 day, or 2 days) after injection of 5 x  10  ~  PFU attenuated ectromalia 
virus. 
$, §,  II As for Table I. 
neither necessary nor sufficient for suppression to occur, but D-region homology 
is sufficient. 
Effect of  Anti- ~ Treatment on Suppressive Activity.  To determine the nature 
of the cells involved in suppression, 6-day immune  spleen cells were treated with 
anti-8  serum  before  injection  into  recipient  mice  1-2  h  after  virus.  Anti-0 
treatment  eliminated the ability of 6-day immune  cells to suppress the response 
(Table V). This result suggests that the suppressive cells are T  cells or that the 
mechanism  of suppression is T-cell dependent. 
Dose Response.  The  effect  of varying  both  the  dose  of suppressive  spleen 
cells and the dose of immunizing  virus used in cell recipients was investigated. 
Suppression  was  observed with  2  x  107  immune  cells per mouse  and  was  not 
improved with higher cells doses (Table VI). Varying the virus dose had no effect 
on suppression within  the dose range  tested (Table VI). 
Kinetics  of Cytotoxic  Activity  in  the  Spleen  after Injection  of Suppressive 
Cells.  In  previous  experiments,  cytotoxic activity in  the  spleens  of recipient 
mice was assayed  6  days after injection of suppressive cells. To determine  the 
kinetics of cytotoxic activity in the spleens of recipient mice, they were assayed 
at  various  times  after  injection  of  suppressive  cells  and  virus.  Significant 
cytotoxic activity was observed 2-4 days after injection, declined significantly on 
day 5,  and increased again on day 6 (Fig. 2).  The cytotoxic activity detected on 
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FIG.  1.  Ability of different immune cell populations to suppress the primary response to 
ectromelia.  Spleen cells were obtained  at various times after infection and  injected into 
recipient mice which had received 2 × 10  ~ PFU attenuated ectromelia virus 1-2 h previously 
(4  ×  107 cells/mouse,  i.v.).  Recipient spleens  were  assayed  for cytotoxicity 6 days  later. 
Percent suppression  values are expressed in relation to percent  specific '~'Cr release ob- 
tained with spleen cells from mice receiving virus only (see footnotes for Table I). Killer to 
target cell ratio was 25:1. 
TABLE  III 
Specificity of Suppressive Effect 
Serum or cells injected*  Percent specific ~Cr release  Percent suppres- 
from infected L-929 cells$  sion§ 
None  57.5 JJ _+ 3.9  0 
Normal serum  48.0  +_  1.6  16.0 
Normal cells  54.5  _+ 0.6  5.2 
Ectromelia-immune serum  30.8  _+ 3.0  46.4 
Ectromelia-immune cells  15.2  +_  1.9  73.6 
Listeria-immune  serum  49.0  _+ 4.0  14.8 
Listeria-immune  cells  51.0  -  3.0  11.3 
* Experimental procedure as described for Table I. Donor cells and serum were obtained from mice 
immunized  10 days  previously with  either  5  ×  104  PFU  attenuated  ectromelia virus or  103 
Listeria monocytogenes. 
$, §,  Jl As for Table I, except that killer to target ratio is 25:1. 
injected; increased  activity  on day 6 may  represent  the beginnings  of a  ~memory' 
or secondary  response.  The  amount  of cytotoxic activity  present  on days 5 and  6, 
after  injection  of suppressive  cells,  was  significantly  lower  than  those  of the 
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TABLE  IV 
Suppressive  Effect of AUogeneic  and F~ Hybrid Immune  Cells 
Immune cells* injected (strain) 
Percent specific 5~Cr 
Percent 
Recipient strain  release from infected 
target cells$  suppression§ 
None  CBA/H  43.7 II ±  1.0  0 
CBA/H  CBA/H  24.2  _+ 0.6  45.0 
(CBA/H  ×  BALB/c)F~  CBA/H  36.2  ±  0.3  17.2 
BALB/c  CBA/H  41.9  ±  1.0  4.1 
A.TL  CBA/H  40.3  ±  0.9  7.8 
None  BALB/c  27.5 II ±  0.9  0 
BALB/c  BALB/c  9.1  -  0.9  66.9 
(CBA/H  ×  BALB/c)F~  BALB/c  22.1  _+ 2.7  19.6 
CBA/H  BALB/c  26.7  ±  0.6  2.9 
A.TL  BALB/c  13.6  -+ 1.0  50.5 
* Experimental procedure as for Table I. Donor mice were infected with 4  ×  103 PFU attenuated 
ectromelia virus 6 days previously. Donor spleen cells were then injected into recipient mice 1-2 
h  after injection of 4  ×  103 PFU attenuated ectromelia virus (4  ×  107 cells per mouse). The H-2 
haplotypes of the mouse strains used are as follows: CBA/H: K k, IA k, IB k, IC k, S k, D~,  • BALB/c: 
K d  , IA ~, IB ~, IC  e, S #, D~,  • A. TL: K', IA k, IBk, IC k, S ~, D d. 
Appropriate target cells were used: when CBA/H (H-2  k ) were the recipient strain, L-929 (H-2 k ) 
cells were used; P-815 (H-2  ~ ) mastocytoma cells served as targets when the recipient strain was 
BALB/c (H-2~). Values are means ±  SE of the mean in groups of three wells with spontaneous 
release subtracted (see Table I). Killer to target ratio was 20:1. 
§,  II As for Table I. 
TABLE V 
Effect of Anti-0 Treatment  on Suppressive Activity 
Cells injected*  Treatment before  Percent specific 5~Cr  Percent suppres- 
injection  release from infected L-  sion§ 
929 cells$ 
None  --  42.6 II-+ 2.0  0 
Immune cells  None  10.9  -+ 2.2  74.0 
Immune cells  NMS  10.4  -+ 1.7  76.0 
Immune cells  Anti-0  40.0  _+ 3.0  6.0 
* Experimental procedure as for Table I. Donor cells were obtained from mice immunized 6 days 
previously with 2  ×  104 PFU attenuated ectromelia virus. Donor cells were then treated with 
either  normal  mouse  serum  (NMS)  or  anti-0  serum  (as  described  in  text)  or  received  no 
treatment at all; they were then injected into recipient mice (4 × 107 cells/mouse); recipient mice 
had been immunized 1-2 h  previously with 2  ×  104 PFU attenuated ectromelia virus. 
$,  §,  II As for Table I, except that killer to target ratio was 25:1. 
Virus  Levels  in  the Spleen  after Injection  of 6-Day Immune  Cells.  After  the 
injection  of 6-day immune  cells 1-2  h  after  virus,  the  virus  levels in the  spleens 
of recipients  were  determined  after  various  further  time  intervals.  The  injection 
of 6-day  immune  cells  significantly  reduced  the  amount  of virus  in  the  spleen 
within  24 h  and  prevented  further  increase  in virus  titres  (Fig.  3).  In contrast, T.  PANG  AND  R.  V.  BLANDEN  475 
TABLE  VI 
Effect of Varying Cell Dose and Virus Dose on Suppressive Activity of 6-Day Immune 
Spleen Cells 
Percent specific 51Cr 
Cells injected per  Virus dose  release from infected L-  Percent suppres- 
mouse*  929 cells  sion$ 
PFU/mouse 
None  2  x  104  42.61] -+  2.0  0 
107  2  ×  104  41.6  _+  1.8  2.3 
2  ×  107  2  x  104  15.8  __+  1.4  62.9 
4  ×  107  2  ×  10  ~  10.9  _+  2.2  74.4 
8  ×  107  2  ×  104  17.8  -+ 0.9  58.2 
None  8  ×  102  46.1  _+  0.6  0 
2  ×  107  8  ×  10  ~  10.3  _+  1.5  77.6 
None  4  ×  10  :~  49.6  _+  2.0  0 
2  ×  107  4  ×  10  :~  15.1  _+  0.7  69.5 
None  2  ×  104  52.1  _+  1.1  0 
2  x  107  2  ×  104  14.6  +__  0.3  72.0 
* Experimental procedure as for Table I. Donor cells were from mice immunized 6 days previously 
with 2  ×  104 PFU attenuated ectromelia virus. 
$,  §,  II As for Table I, except that killer to target ratio was 25:1. 
when no  cells  were  injected,  virus  levels increased to  a  peak  on day 2  and 
rapidly declined to very low levels by day 5 (Fig. 3). 
The Effect of Adult Thymectomy on the Primary Immune Response to Ectro- 
melia.  Adult CBA/H mice were either thymectomized  or sham-operated and at 
various times after the operation immunized with ectromelia virus.  Cytotoxic 
activity in the spleen was then assayed 6 or  10 days after immunization. No 
difference in the level of cytotoxic activity was observed between thymectomized 
mice and sham-operated controls at either 6 or 10 days after primary immuniza- 
tion (Table VII). It can thus be concluded that adult thymectomy  has little effect 
on the primary immune response to ectromelia infection. 
Discussion 
T cells active against viral and bacterial infection in mice appear in lymphoid 
tissues or central lymph within 3 days after infection (10). Since live vaccines are 
the most effective immunizing agents, the efficient induction of these T  cells 
probably requires antigen presentation in a particular manner after infection of, 
or  processing by,  macrophages  or,  in  the  case  of viruses,  infection of other 
potential 'stimulator' cells (11). Furthermore, recent studies on the infection of 
mice with lymphocytic choriomeningitis virus (12, 13), ectromelia virus (6,  7, 
14),  vaccinia virus (15), Sendai virus,  4 and the bacterium Listeria  monocyto- 
genes  (16) suggest that effector T  cells  in these  systems recognize antigenic 








DAYS AFTER  INFECTION 
FIa.  2.  Kinetics of cytotoxic activity  in the  spleen after  injection of suppressive cells. 
Recipient mice immunized with 2  x  104 PFU attenuated ectromelia virus received either 5 
x  107 6-day immune spleen cells 1-2 h  after virus (O--O) or received no further treatment 
(O--Q).  Spleens of recipients were  then  assayed at  various further times for  cytotoxic 
activity as described in text. Values are means of three wells with vertical bars represent- 
ing standard error of the mean. All values are corrected for medium release and killer to 
target ratio was 60:1. 
patterns which are not simply virus-specified or bacterial products alone, but 
are  produced by the action of host cell gene(s)  as well  as the genome of the 
infectious agent (11). In the viral systems, the host cell genes required map in 
the K or D regions of the H-2 gene complex (7), i.e., they may be identical to or 
closely linked to the genes dictating major histocompatibility antigens. 
Ectromelia virus multiplies in the spleen for 2-3 days after primary infection 
by the intravenous route and is then eliminated as the effector T-cell response 
increases.  Effector T-cell activity in the spleen reaches a  peak 5-6 days after 
infection and then declines (4, 10). However, little is known about the regulation 
of effector T-cell production in the primary response to infection. Regulation can 
be envisaged to occur at two levels: (a) At the stage of induction of precursors of 
effector T cells, i.e., limitation of the numbers of precursors induced. (b) Regula- 
tion of effector T-cell proliferation after induction has taker, place. In relation to 
regulation at the level of precursor induction, the simplest regulatory mecha- 
nism would be elimination of antigen. The importance of such a mechanism is 
suggested by the data presented in this report. 
In the light of the results obtained it is most likely that the suppressive effect 
of ectromelia-immune spleen cells and serum on the primary response is due to T.  PANG  AND  R.  V.  BLANDEN  477 
4- 







:  \  ',  \ 
\  , 
5 
DAYS AFTER INFECTION 
FI~.  3.  Virus  levels in the spleen  after injection of 6-day immune cells. Recipient  mice 
were injected with 2 × 10  ~  PFU attenuated ectromelia virus; 1-2 h later they were injected 
with either 4  x  107 6-day immune spleen  cells (O--O) or received  no further treatment 
(O--O). Spleens of recipients were then assayed for virus content at various further times 
using a plaque assay on L-929 cells (see text). Values are means of four mice with vertical 
bars representing standard errors of the mean. 
clearance  of virus  and  virus-infected  cells,  and  therefore  decreased  levels  of 
virus-induced antigenic patterns.  The process of viral clearance is triggered by 
effector  T  cells.  Thus  removal  of  the  inductive  stimulus  necessary  for  the 
response seems to be triggered by the effector cells produced by that response, a 
feedback  mechanism  of the  simplest  kind.  In  support  of this  conclusion  is, 
firstly,  the  finding  that  6-day  immune  spleen  cells  are  the  most  effective 
suppressors (Fig.  1); this corresponds to the peak of effector activity in vitro and 
in vivo, i.e., 6-day cells are the most potent killers in an in vitro cytotoxic assay 
as well as being the  most effective in triggering clearance of virus from target 
organs  when injected  into infected recipient  mice. 3 Secondly,  suppression  was 
shown to be anti-0 sensitive (Table V), thus indicating that the active suppressor 
cell is a T cell or that the mechanism of suppression is T-cell dependent. Thirdly, 
the suppressive effect, with respect to the dose of immune cells injected, is dose- 
dependent  only up to a  certain  ~threshold'  level (Table  VI); it was shown that 
although 107 cells do not suppress the response, strong suppression was produced 
with 2  x  107 cells and not improved with 4  x  107 or 8  x  107 cells. This suggests 
that a 'minimum' cell dose of 2  x  107 cells was sufficient to eliminate most of the 
virus-induced  antigen,  thereby  producing  suppression.  With  respect  to  virus 
dose, strong suppression was produced by 2  x  107 cells, irrespective of the dose of 478  FEEDBACK  SUPPRESSION  BY EFFECTOR  T  CELLS 
TABLE VII 
The Effect of Adult Thymectomy on the Primary Immune Response to Ectromelia* 
Weeks after  Days after immu- 
ATx  nization 
Percent specific 5'Cr release from infected L-929 cells$ 
Sham  ATx 
3  6  48.9§  ±  4,1  53.2 +  ±  4.4 
10  3.5  ±  1.5  3.4  ±  1.3 
4  6  48.5  _+  4.0  44.6  +_  6.4 
10  0.9  _+  3.6  7.0  ±  4.2 
5  6  32.0  -  3.0  36.9  ± 3.8 
10  13.3  ± 1.0  11.5  ± 1.7 
6  6  28.3  ± 1.3  23.8  ± 4.6 
10  10.6  ± 1.7  11.7  ± 0.9 
7  6  52.7  ± 1.7  44.9  ± 3.4 
10  17.4  ± 2.7  20.0  ± 2.9 
8  6  55.0  ± 3.0  58.5  +_ 1.3 
10  16.0  ± 1.7  19.5  ÷ 2.4 
* Adult CBA/H  mice {8-9 wk) were either thymectomizod or sham operated. At various times after 
the operation they were immunized with 5 × 104 PFU attenuated  ectromelia virus, and spleens 
were assayed for cytotoxic activity either 6 days or 10 days after immunization as described in 
text. 
As for Table I. 
§ Significantly greater  release than from uninfected L-929 cells tP < 0.001). 
virus (Table VI), and it may be argued that this dose of cells was sufficient to 
remove  most  of the  virus-induced  antigen,  even  at  the  higher  virus  doses. 
Fourthly, virus was barely detectable in the spleens of recipients after injection 
of immune cells (Fig. 3).  Fifthly, for suppression to occur, D-region homology at 
the H-2 gene complex between donor and recipient mice was sufficient;/-region 
homology alone was neither necessary nor sufficient for suppression (Table IV). 
Since the major genes required for cytolysis mediated by T cells against ectrome- 
lia-infected  target  cells  (7)  and  T-cell-triggered  virus  clearance  in  vivo  ~ are 
located in the K  or D  regions of the H-2 gene complex, this is further evidence for 
effector T  cells being responsible for the observed suppression. 
Therefore,  the  following  scheme  may  be  operative:  effector  T  cells  in  the 
injected donor population recognize and kill virus-infected cells in target organs 
(including  the  spleen).  This  is  followed  by  monocytic  invasion  into  foci  of 
infection  in  these  target  organs  (3,  10). This  invasion  then  results  in  the 
elimination by phagocytosis and intracellular degradation of much of the virus- 
induced antigen necessary for the  induction of the response,  thus resulting in 
suppression of the primary response as indicated by decreased cytotoxic activity 
in the spleen 4-6 days later.  It was also shown that the suppressive effect was 
observed when cells or serum were injected 1-2 h  or 1 day, but not 2 days, after 
virus  (Table  II).  This  suggests  that  the  sequence  of events  described  above, T.  PANG  AND  R.  V.  BLANDEN  479 
which results in a  suppression of the primary response, occurs mainly in the 
first 24-48 h  after viral infection and injection of suppressive cells. The clear- 
ance of infection in target organs and elimination of the bulk of viral antigen 
demonstrated by immunofluorescence has been shown to occur in ectromelia 
virus infection 24 h  after injecting immune spleen cells (2,  3).  Furthermore, it 
was recently reported that the injection of syngeneic T cells into irradiated mice 
after immunization with allogeneic cells suppresses the cell-mediated cytotoxic 
response against the alloantigens (17). In analogy to the scheme described here, 
a possible explanation of this result would be as follows: the injected syngeneic T 
cells would accelerate the cytotoxic T-cell response and consequent rejection of 
the  allogeneic  cells  (or  antigenic  stimulus),  thus  reducing  the  duration  of 
availability of antigen and resulting in an earlier but lower peak to the cytotoxic 
T-cell response. 
Although virus  clearance triggered by T  cells  is  probably the  most likely 
explanation for the observed suppression, the finding that immune serum can 
also suppress the primary response to a certain extent (Tables I and II) raises the 
possibility that there are factors produced by B cells in the injected population 
which prevent induction of cytotoxic T  cells.  This could occur in a  number of 
ways. Firstly, neutralizing antibody could indirectly reduce the inductive stimu- 
lus by limiting further infection of stimulator cells. Secondly, other antibodies 
may have a blocking effect on induction by either masking antigen on a virus- 
infected cell or by forming antigen-antibody complexes (with appropriate 'viral' 
antigens) which blockade T-cell receptors. Such a receptor blockade mechanism 
by specific immune complexes has been suggested for the response to sheep red 
blood cells (18). Thirdly, it is possible that antibodies promote monocytic inva- 
sion  into  foci  of infection which  then  removes  the  inductive  stimulus  in  a 
manner similar to sensitized T cells (2,  3).  It should be pointed out, however, 
that the nature of suppressive factor(s) in immune serum  are  unknown and 
further characterization is necessary. 
The previous discussion suggests that removal of antigen plays an important 
role in the regulation of  the primary response at the level of  precursor induction. 
However, other regulatory mechanisms must operate after induction has taken 
place. Several reports have proposed that two types ofT cells are required for the 
optimal generation of graft versus host reactions in mice (19, 20). One of these 
types ofT cells (called Tj cells), normally present in the thymus and spleen, may 
decrease in numbers 2-6 wk after adult thymectomy  (20). It is possible that this 
newly derived T  cell  is  playing a  regulatory role  (e.g.,  in the  production of 
suppressor T cells) which is responsible for the decline of the primary response 
after  day 6.  If this  were  the  case,  the  primary response  in  thymectomized 
animals, where these T, cells are presumably absent, may remain at an elevated 
level. As was shown, the response of thymectomized mice and sham-operated 
mice to ectromelia was identical (Table  VII).  It is thus unlikely that newly- 
derived TI cells play a regulatory role in this system. Alternatively, it is possible 
that  the  decline  in  the  primary response  is  due  to  suppressive  action  by  a 
suppressor cell other than T1 (e.g., a population that is generated with the same 
kinetics as the effector T cells). A third possibility is that effector cell activity 
declines because effector cells possess an inbuilt regulatory mechanism which, 480  FEEDBACK  SUPPRESSION  BY  EFFECTOR  T  CELLS 
after  a  set  number  of cell  divisions,  instructs  these  cells  to  dedifferentiate, 
probably  into  small  lymphocytes which  later  become  'memory'  cells.  These 
possibilities are currently under investigation. 
Summary 
Spleen  cells  and  serum  from  mice  immunized with  ectromelia virus  sup- 
pressed the immune response to infectious virus when transferred intravenously 
into  recipient  mice  given  an  immunizing  virus  dose.  The  suppression  was 
reflected in decreased cytotoxic T-cell activity directed against H-2  compatible 
virus-infected target cells in the spleens of recipients. Suppression was observed 
when immune cells or serum were transferred 1-2 h or 1 day after immunization 
of recipients, but not 2 days after, and was maximal when 6-day immune spleen 
cells were used as suppressor cells. H-2 compatibility between donor and recipi- 
ent mice was necessary for suppression to be expressed. Use of recombinant mice 
showed that/-region compatibility was  neither sufficient nor necessary,  and 
that D-region compatibility was sufficient. Specificity of suppression was sug- 
gested by the finding that cells and serum from mice immunized with Listeria 
monocytogenes,  a  bacterium,  had  no suppressive activity on the antiviral re- 
sponse. Anti-0 treatment eliminated the ability of immune cells to suppress, and 
the suppressive effect was not markedly dose-dependent with respect to both cell 
dose and virus dose under the conditions employed. Virus levels in the spleens of 
recipients  were  significantly reduced  after  injection  of immune  cells.  Adult 
thymectomy had no effect on the primary immune response to ectromelia virus 
infection, thus indicating no role for T, cells in the suppressive mechanism. 
The results obtained therefore suggested that suppression in this system was 
due to effector T  cells which triggered clearance of virus (and thus,  of virus- 
induced antigens) necessary for the induction of precursors of effector T  cells, 
and that this simple feed-back mechanism normally plays an important role in 
the regulation of the primary immune response to ectromelia infection at the 
level of precursor induction.  The existence of other postinduction regulatory 
mechanisms, however, is unknown and under investigation. 
We are very grateful to Doctors C. S. David and D. C. Shreffler for providing a breeding nucleus of 
A.TL mice. 
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